6009

SHH:600998

Jointown Pharmaceutical Group Co., Ltd

  • Stock

CNY

Last Close

5.24

30/04 07:00

Market Cap

23.90B

Beta: 0.13

Volume Today

81.05M

Avg: 8.90M

PE Ratio

6.47

PFCF: 7.69

Dividend Yield

6.89%

Payout:76.15%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.62B
-
7.21B
28.28%
9.13B
26.63%
11.17B
22.27%
13.04B
16.74%
13.98B
7.25%
14.42B
3.16%
15.15B
5.01%
16.36B
8.05%
18.66B
14.05%
average payables
7.28B
-
10.34B
41.95%
14.13B
36.64%
17.69B
25.23%
22.30B
26.09%
26.73B
19.85%
29.56B
10.58%
32.63B
10.38%
36.73B
12.56%
36.97B
0.67%
average receivables
10.17B
-
12.50B
22.98%
14.87B
18.95%
19.68B
32.31%
26.45B
34.40%
31.27B
18.23%
34.25B
9.54%
36.57B
6.77%
38.79B
6.08%
29.94B
22.81%
book value per share
3.36
-
3.89
15.65%
4.66
19.93%
7.39
58.56%
6.75
8.70%
6.20
8.19%
7.62
23.00%
8.15
6.92%
12.76
56.62%
7.54
40.92%
capex per share
-0.41
-
-0.42
2.90%
-0.48
13.43%
-0.44
7.39%
-0.66
50.59%
-0.39
40.61%
-0.51
29.17%
-0.48
5.15%
-0.64
33.46%
0.27
141.66%
capex to depreciation
-5.85
-
-4.57
21.89%
-4.15
9.28%
-3.10
25.20%
-4.50
45.11%
-2.40
46.72%
-2.83
18.11%
-2.11
25.50%
-1.69
19.98%
1.35
180.14%
capex to operating cash flow
5.51
-
-2.31
142.02%
-2.67
15.26%
1.08
140.39%
-1.49
237.85%
-0.43
71.00%
-0.42
1.77%
-0.40
5.28%
-0.31
22.16%
0.22
170.82%
capex to revenue
-0.02
-
-0.02
11.62%
-0.02
8.15%
-0.01
21.10%
-0.02
41.24%
-0.01
42.47%
-0.01
9.69%
-0.01
13.84%
-0.01
21.81%
0.01
178.89%
cash per share
1.55
-
2.54
64.19%
2.17
14.60%
3.45
59.16%
4.64
34.54%
3.90
16.08%
5.18
32.90%
6.37
23.06%
9.06
42.26%
4.36
51.90%
days of inventory on hand
60.37
-
64.62
7.03%
65.32
1.08%
65.67
0.55%
63.69
3.03%
56.57
11.18%
53.44
5.53%
50.31
5.85%
48.52
3.55%
53.19
9.61%
days payables outstanding
82.63
-
95.87
16.02%
104.31
8.81%
103.33
0.95%
116.64
12.89%
112.64
3.43%
112.48
0.15%
110.76
1.53%
110.77
0.02%
106.04
4.27%
days sales outstanding
106.72
-
95.68
10.34%
99.30
3.79%
111.60
12.39%
126.86
13.67%
118.31
6.74%
119.36
0.89%
109.98
7.86%
105.79
3.81%
71.41
32.49%
debt to assets
0.27
-
0.23
16.20%
0.18
22.96%
0.16
7.26%
0.18
9.14%
0.20
14.76%
0.22
7.03%
0.20
9.72%
0.16
16.64%
0.13
18.51%
debt to equity
0.84
-
0.80
5.63%
0.60
24.05%
0.46
23.19%
0.64
38.55%
0.78
20.59%
0.81
4.47%
0.73
10.50%
0.62
14.97%
0.52
15.81%
dividend yield
0.02
-
0.01
22.65%
0.02
47.94%
0.02
4.94%
0.04
61.72%
0.04
8.80%
0.02
46.69%
0.06
180.40%
0.08
38.68%
0.04
46.28%
earnings yield
0.02
-
0.02
10.18%
0.03
18.63%
0.05
76.31%
0.05
10.03%
0.06
18.89%
0.09
46.70%
0.09
2.07%
0.12
43.07%
0.10
17.02%
enterprise value
31.14B
-
32.99B
5.92%
35.26B
6.88%
31.45B
10.80%
25.73B
18.20%
31.13B
21.02%
37.79B
21.39%
30.66B
18.87%
14.92B
51.35%
16.90B
13.32%
enterprise value over ebitda
22.94
-
18.57
19.02%
16.43
11.57%
12.07
26.50%
8.08
33.05%
7.55
6.56%
7.97
5.49%
7.47
6.29%
2.93
60.78%
3.33
13.59%
ev to operating cash flow
-181.40
-
75.66
141.71%
81.75
8.05%
-31.07
138.01%
21.05
167.75%
11.25
46.57%
10.97
2.44%
8.86
19.22%
3.74
57.78%
3.56
4.85%
ev to sales
0.76
-
0.67
12.28%
0.57
13.90%
0.43
25.74%
0.30
30.58%
0.31
5.99%
0.34
8.95%
0.25
26.52%
0.11
57.59%
0.11
5.99%
free cash flow per share
-0.48
-
-0.24
50.54%
-0.30
24.85%
-0.85
185.64%
-0.22
74.49%
0.52
340.31%
0.69
33.26%
0.72
4.01%
1.42
96.89%
0.95
33.40%
free cash flow yield
-0.04
-
-0.02
54.37%
-0.02
17.94%
-0.07
212.59%
-0.02
66.55%
0.05
345.37%
0.06
3.86%
0.07
28.32%
0.16
122.31%
0.17
7.33%
graham net net
-0.12
-
-1.17
840.80%
-1.59
35.17%
-0.37
76.53%
-1.44
285.92%
-2.04
41.82%
-2.03
0.54%
-1.79
11.66%
-3.61
101.35%
-3.63
0.66%
graham number
4.27
-
5.02
17.53%
6.17
22.72%
9.85
59.83%
8.63
12.47%
8.92
3.40%
13.57
52.16%
12.50
7.88%
17.61
40.87%
8.76
50.24%
income quality
-0.30
-
0.62
305.02%
0.48
23.01%
-0.69
244.08%
0.88
228.74%
1.55
75.64%
1.02
34.52%
1.33
30.35%
1.74
31.52%
2.18
25.21%
intangibles to total assets
0.03
-
0.03
12.08%
0.03
2.88%
0.03
12.63%
0.02
15.52%
0.04
70.22%
0.03
3.40%
0.03
5.01%
0.03
8.10%
0.03
0.83%
interest coverage
1.55
-
1.57
1.29%
1.56
0.73%
2.71
73.49%
2.06
24.10%
2.92
42.01%
4.24
44.94%
3.14
25.95%
3.57
13.76%
2.29
35.72%
interest debt per share
3.01
-
3.32
10.23%
3.10
6.78%
3.72
20.22%
4.67
25.40%
5.22
11.79%
6.54
25.28%
6.31
3.46%
8.51
34.79%
3.52
58.57%
inventory turnover
6.05
-
5.65
6.57%
5.59
1.07%
5.56
0.55%
5.73
3.12%
6.45
12.58%
6.83
5.86%
7.25
6.21%
7.52
3.68%
6.86
8.77%
invested capital
0.84
-
0.80
5.63%
0.60
24.05%
0.46
23.19%
0.64
38.55%
0.78
20.59%
0.81
4.47%
0.73
10.50%
0.62
14.97%
27.33B
4,429,989,100,053.76%
market cap
28.15B
-
31.65B
12.42%
33.67B
6.41%
31.49B
6.49%
26.54B
15.71%
28.75B
8.33%
34.91B
21.41%
28.38B
18.70%
16.89B
40.48%
21.23B
25.65%
net current asset value
3.84B
-
4.48B
16.84%
5.45B
21.49%
10.96B
101.31%
10.76B
1.81%
9.72B
9.68%
10.94B
12.55%
12.31B
12.46%
12.07B
1.91%
12.31B
2.01%
net debt to ebitda
2.20
-
0.75
65.80%
0.74
2.20%
-0.02
102.16%
-0.26
1,513.06%
0.58
325.28%
0.61
5.25%
0.56
8.61%
-0.39
169.73%
-0.85
119.33%
net income per share
0.24
-
0.29
19.44%
0.36
25.58%
0.58
61.11%
0.49
16.09%
0.57
16.44%
1.07
88.24%
0.85
20.62%
1.08
26.71%
0.56
48.50%
operating cash flow per share
-0.07
-
0.18
344.87%
0.18
1.59%
-0.41
329.32%
0.45
209.25%
0.91
104.77%
1.20
31.50%
1.20
0.13%
2.06
71.47%
1.21
41.18%
payables turnover
4.42
-
3.81
13.81%
3.50
8.09%
3.53
0.96%
3.13
11.42%
3.24
3.56%
3.25
0.15%
3.30
1.55%
3.29
0.02%
3.44
4.46%
receivables turnover
3.42
-
3.81
11.54%
3.68
3.65%
3.27
11.02%
2.88
12.03%
3.09
7.23%
3.06
0.89%
3.32
8.53%
3.45
3.96%
5.11
48.14%
research and ddevelopement to revenue
0.00
-
0.00
18.52%
0.00
20.88%
0.00
38.90%
0.00
239.31%
0.00
14.84%
0.00
53.31%
0.00
39.43%
0.00
20.23%
0.00
3.08%
return on tangible assets
0.02
-
0.02
8.68%
0.02
6.12%
0.03
22.22%
0.02
27.89%
0.03
22.56%
0.04
56.58%
0.03
25.25%
0.02
20.91%
0.02
3.66%
revenue per share
17.70
-
20.61
16.44%
25.45
23.49%
29.87
17.38%
31.85
6.62%
32.87
3.23%
38.71
17.76%
42.61
10.08%
72.74
70.69%
38.41
47.20%
roe
0.07
-
0.07
3.28%
0.08
4.71%
0.08
1.61%
0.07
8.10%
0.09
26.82%
0.14
53.03%
0.10
25.76%
0.08
19.10%
0.09
7.13%
roic
0.03
-
0.04
12.01%
0.05
25.81%
0.06
16.92%
0.05
17.94%
0.08
83.92%
0.09
2.80%
0.07
20.16%
0.09
27.68%
0.06
27.58%
sales general and administrative to revenue
0.00
-
0.01
18.71%
0.01
2.43%
0.01
17.97%
0.01
8.50%
0.01
3.10%
0.01
3.03%
0.01
14.03%
0.01
9.84%
0.01
49.10%
shareholders equity per share
3.36
-
3.89
15.65%
4.66
19.93%
7.39
58.56%
6.75
8.70%
6.20
8.19%
7.62
23.00%
8.15
6.92%
12.76
56.62%
6.14
51.93%
stock based compensation to revenue
tangible asset value
7.27B
-
8.88B
22.08%
10.89B
22.70%
18.23B
67.31%
18.96B
4.04%
19.39B
2.26%
22.79B
17.53%
24.22B
6.26%
25.87B
6.81%
26.67B
3.09%
tangible book value per share
3.13
-
3.69
17.72%
4.50
22.06%
7.36
63.49%
6.93
5.87%
6.41
7.55%
7.96
24.21%
8.43
5.94%
13.40
58.93%
6.82
49.09%
working capital
5.51B
-
6.21B
12.76%
6.90B
11.16%
12.77B
84.97%
12.79B
0.15%
12.95B
1.29%
14.82B
14.38%
15.78B
6.46%
15.97B
1.26%
15.56B
2.59%

All numbers in CNY (except ratios and percentages)